PharmaSGP Holding SE
XETRA:PSG
PharmaSGP Holding SE
XETRA:PSG
Price:
22.6 EUR
-1.74%
Updated:
May 6, 2024
PharmaSGP Holding SE
Cash from Operating Activities
|
PharmaSGP Holding SE
Cash from Operating Activities Peer Comparison
Comparables:
ATAI
BAYN
MRK
93M1
DMP
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PharmaSGP Holding SE
XETRA:PSG
|
Cash from Operating Activities
€24.7m
|
CAGR 3-Years
12%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
|
|
ATAI Life Sciences NV
NASDAQ:ATAI
|
Cash from Operating Activities
-$84.1m
|
CAGR 3-Years
-59%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Bayer AG
XETRA:BAYN
|
Cash from Operating Activities
€5.1B
|
CAGR 3-Years
1%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
0%
|
|
|
Merck KGaA
XETRA:MRK
|
Cash from Operating Activities
€3.8B
|
CAGR 3-Years
3%
|
CAGR 5-Years
11%
|
CAGR 10-Years
5%
|
|
|
MPH Health Care AG
XETRA:93M1
|
Cash from Operating Activities
€12m
|
CAGR 3-Years
56%
|
CAGR 5-Years
64%
|
CAGR 10-Years
N/A
|
|
|
Dermapharm Holding SE
XETRA:DMP
|
Cash from Operating Activities
€218.6m
|
CAGR 3-Years
18%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
See Also
What is PharmaSGP Holding SE's Cash from Operating Activities?
Cash from Operating Activities
24.7m
EUR
24.7m
EUR
Based on the financial report for Dec 31, 2022, PharmaSGP Holding SE's Cash from Operating Activities amounts to 24.7m EUR.
What is PharmaSGP Holding SE's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 5Y
12%
12%
Over the last year, the Cash from Operating Activities growth was 102%. The average annual Cash from Operating Activities growth rates for PharmaSGP Holding SE have been 12% over the past three years , 12% over the past five years .
You don't have any saved screeners yet
